Correlation of Serum BACE1 With Emergence Delirium in Postoperative Patients: A Preliminary Study
Authors:
Open Access
- 28 October 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 12, 555594
Abstract
Background: The mechanism underlying delirium, a common acute fluctuating mental state, may be related to the activation of a neuroinflammatory response. In this study, we attempted to investigate whether plasma inflammatory response markers, vascular and cerebrovascular injury-related markers, and neurodegeneration-associated markers were associated with emergence delirium (ED). Methods: Patients aged 50 years or above who underwent elective laparoscopic surgery under general anesthesia were included in this study. Delirium was assessed postoperatively with the Richmond Agitation Sedation Scale (RASS) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scale. Plasma samples were collected from ED patients and non-ED patients to test concentrations of inflammation markers, including interleukin 6 (IL-6), chitinase 3-like 1 (CHI3L1), S100 calcium-binding protein B (S100B), lipoprotein-associated phospholipase-A2 (Lp-PLA2), and macrophage migration inhibitory factor (MIF); vascular and cerebrovascular injury-related markers, including intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1); and neurodegeneration-associated markers, including alpha-synuclein (α-Syn) and β-secretase 1 (BACE1). Binary logistic regression analysis was performed to analyze the relationship between biomarkers and ED, and receiver operating characteristic (ROC) curves were used to analyze the diagnostic value of biomarkers. Results: A total of 104 patients were included in this study, with an average age of 63.69 ± 7.21. IL-6 (OR = 2.73, 95% CI: 1.66–6.44, P = 0.022), S100B (OR = 4.74, 95% CI: 1.88–11.95, P = 0.001), and BACE1 (OR = 6.54, 95% CI: 2.57–16.65, P < 0.000) were independent biological indicators for the occurrence of ED.CHI3L1, Lp-PLA2, MIF, ICAM-1, VCAM-1, and α-Syn were unrelated to ED. Plasma BACE1 level had a possible diagnostic value for ED [area under curve (AUC) = 0.75, 95% CI: 0.66–0.85], whereas plasma IL-6 (AUC = 0.62, 95% CI: 0.51–0.73) and S100B (AUC = 0.65, 95% CI: 0.54–0.76) levels had little diagnostic value for distinguishing ED vs. non-ED. Conclusion: Higher levels of systemic inflammation marker IL-6, cerebral inflammation marker S100B, and neurodegeneration-associated marker BACE1 are related to ED. Plasma BACE1 may be a potential diagnostic biomarker for ED.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 33 references indexed in Scilit:
- Delirium in elderly peopleThe Lancet, 2014
- Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathwayNeurochemistry International, 2012
- Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's diseaseInternational Journal of Neuropsychopharmacology, 2011
- Cortisol, interleukins and S100B in delirium in the elderlyBrain and Cognition, 2010
- Emergence delirium: a re-emerging interestSeminars in Anesthesia, Perioperative Medicine and Pain, 2006
- Emergence delirium in adults in the post-anaesthesia care unitBritish Journal of Anaesthesia, 2006
- Recovery Room Delirium Predicts Postoperative Delirium After Hip-Fracture RepairAnesthesia & Analgesia, 2005
- Gene structure and organization of the human β‐secretase ( BACE ) promoterThe FASEB Journal, 2004
- Monitoring Sedation Status Over Time in ICU PatientsJAMA, 2003
- Delirium in Mechanically Ventilated PatientsJAMA, 2001